Fulgent Genetics Reports Financial Results for the Third Quarter of 2016
Revenue Grows 72% to $5.0 Million Over Third Quarter of Last Year GAAP Net Loss of $1.0 Million; non-GAAP Earnings of $1.1 Million Gross Margin, Adjusted EBITDA and Cash Flow Continue to Grow TEMPLE CITY, Calif., Nov. 03, 2016 (GLOBE NEWSWIRE) -- Fulgent …